HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Gram-negative bacterial cellulitis — Clinical Guidelines

Overview

Gram-negative bacterial cellulitis is an infection characterized by inflammation and infection of the skin and subcutaneous tissues, primarily caused by multidrug-resistant (MDR) Gram-negative bacteria such as Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli. 4

Diagnosis

Clinical presentation includes localized pain, swelling, erythema, and warmth.

Laboratory tests: Elevated white blood cell count and C-reactive protein levels.

Imaging: Ultrasound or MRI may help assess extent and complications like abscess formation.

Cultures: Essential for identifying the specific pathogen and its antibiotic sensitivities 4.

Management

First-line treatments: Ceftazidime/avibactam (for MDR pathogens) 1, ceftolozane/tazobactam 5, and cefiderocol 3.

Adjunctive therapies: Consider polymyxins (colistin or polymyxin B) for severe, resistant cases, though with caution due to renal toxicity 2.

Supportive care: Includes fluid resuscitation, wound care, and monitoring for complications like sepsis 4.

Special Populations

Renal impairment: Use of polymyxins requires careful monitoring due to increased risk of acute kidney injury 2.

Elderly: Higher susceptibility to complications; close monitoring of adverse drug reactions is essential 1 3.

Key Recommendations

Initiate empirical broad-spectrum antibiotic therapy targeting MDR Gram-negative bacteria based on local resistance patterns (Evidence: Moderate 4).

Adjust antibiotic choice based on culture and sensitivity results to optimize efficacy and minimize resistance development (Evidence: Moderate 4).

Monitor renal function closely, especially when using nephrotoxic agents like polymyxins (Evidence: Strong 2).

Consider the patient's comorbidities and renal status when selecting appropriate antibiotics to mitigate adverse events (Evidence: Moderate 1 2).

References

1 Zheng X, Peng Y, Ou YX, You BB, Zhang L, Cheng Y et al.. Real-world study of adverse events associated with ceftazidime/avibactam based on the U.S. Food and Drug Administration adverse event reporting system database. Frontiers in cellular and infection microbiology 2026. link 2 Wu T, Shi Y, Xu C, Zhu B, Li D, Li Z et al.. A pharmacovigilance study of adverse events associated with polymyxins based on the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database. Expert opinion on drug safety 2025. link 3 Lin H, Zhu C, Liu S, Bi Y, Hu J, Ju M. Post-market safety profile of cefiderocol: a real-world pharmacovigilance exploratory analysis based on U.S. FDA adverse event reporting system (FAERS). BMC pharmacology & toxicology 2025. link 4 Righi E, Mutters NT, Guirao X, Del Toro MD, Eckmann C, Friedrich AW et al.. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2023. link 5 Puzniak L, Dillon R, Palmer T, Collings H, Enstone A. Real-world use of ceftolozane/tazobactam: a systematic literature review. Antimicrobial resistance and infection control 2021. link 6 Yen YT, Tsang C, Cameron TA, Ankrah DO, Rodou A, Stathopoulos C. Importance of conserved residues of the serine protease autotransporter beta-domain in passenger domain processing and beta-barrel assembly. Infection and immunity 2010. link 7 Verhoef J, Mattsson E. The role of cytokines in gram-positive bacterial shock. Trends in microbiology 1995. link88902-7) 8 Hamada S, Furuta T, Okahashi N, Nisizawa T, Yamamoto T, Chiba J. Characterization of a monoclonal antibody specific for lipoteichoic acid from various gram-positive bacteria. Microbiology and immunology 1984. link

Gram-negative bacterial cellulitis